D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$667M |
| 2 |
NVIDIA
NVDA
|
+$584M |
| 3 |
ConocoPhillips
COP
|
+$432M |
| 4 |
Amazon
AMZN
|
+$418M |
| 5 |
Johnson & Johnson
JNJ
|
+$377M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$836M |
| 2 |
Meta Platforms (Facebook)
META
|
+$525M |
| 3 |
Apple
AAPL
|
+$453M |
| 4 |
CELG
Celgene Corp
CELG
|
+$349M |
| 5 |
Pfizer
PFE
|
+$306M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.58% |
| 2 | Consumer Discretionary | 13.65% |
| 3 | Healthcare | 12.98% |
| 4 | Industrials | 7.3% |
| 5 | Financials | 7.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Icon
ICLR
$12.8B
| $57.3M | 0.07% |
372,219
+25,723
| +7% | +$3.61M |
|
327
Insmed
INSM
$23.2B
| $56.8M | 0.07% |
2,218,947
+1,625,381
| +274% | +$45.3M |
|
328
PUT
Kraft Heinz
KHC
$30.4B
| $56.6M | 0.07% |
1,824,600
+155,000
| +9% | +$4.89M |
|
329
Stanley Black & Decker
SWK
$14.2B
| $56.6M | 0.07% |
391,476
+374,617
| +2,222% | +$52.8M |
|
330
F5
FFIV
$22.1B
| $56.4M | 0.07% |
387,289
-42,053
| -10% | -$6.3M |
|
331
Healthpeak Properties
DOC
$15.4B
| $55.8M | 0.07% |
1,746,343
-369,721
| -17% | -$11.5M |
|
332
InterDigital
IDCC
$6.68B
| $55.8M | 0.07% |
867,162
+201,100
| +30% | +$13.4M |
|
333
Middleby
MIDD
$6.05B
| $55.8M | 0.07% |
411,432
+42,620
| +12% | +$5.73M |
|
|
WBA
334
PUT
DELISTED
Walgreens Boots Alliance
WBA
| $55.8M | 0.07% |
1,020,800
+836,800
| +455% | +$44.5M |
|
335
CALL
FedEx
FDX
$74.5B
| $55.7M | 0.07% |
339,400
+10,500
| +3% | +$1.84M |
|
336
Philip Morris
PM
$301B
| $55.5M | 0.07% |
707,222
+89,664
| +15% | +$7.41M |
|
337
UnitedHealth
UNH
$382B
| $55.2M | 0.07% |
226,089
+138,981
| +160% | +$33.4M |
|
|
OPLN
338
Openlane
OPLN
$4.17B
| $55M | 0.07% |
2,201,398
-6,357,292
| -74% | -$137M |
|
339
ASML
ASML
$675B
| $54.9M | 0.07% |
263,994
+50,024
| +23% | +$9.95M |
|
340
Alphabet (Google) Class C
GOOG
$3.9T
| $54.6M | 0.07% |
1,009,920
-1,993,260
| -66% | -$115M |
|
341
Arch Capital
ACGL
$36.1B
| $54.5M | 0.07% |
1,470,237
-146,070
| -9% | -$4.98M |
|
342
Brown-Forman Class B
BF.B
$12B
| $54.4M | 0.07% |
981,899
+863,186
| +727% | +$46.1M |
|
343
Pacira BioSciences
PCRX
$1.02B
| $54.3M | 0.07% |
1,248,573
+306,129
| +32% | +$13M |
|
|
AMED
344
DELISTED
Amedisys
AMED
| $54.3M | 0.07% |
446,941
+76,403
| +21% | +$9.07M |
|
345
Ametek
AME
$55.5B
| $54.2M | 0.07% |
596,129
+68,872
| +13% | +$5.9M |
|
346
M&T Bank
MTB
$36.2B
| $54.1M | 0.07% |
318,212
-161,656
| -34% | -$26.8M |
|
347
Voya Financial
VOYA
$8.94B
| $53.8M | 0.07% |
972,384
+130,108
| +15% | +$6.97M |
|
348
Host Hotels & Resorts
HST
$16.8B
| $53.6M | 0.07% |
2,940,455
-771,443
| -21% | -$14.5M |
|
|
DOCU
349
DocuSign
DOCU
$9.63B
| $53.4M | 0.07% |
1,074,395
+506,322
| +89% | +$27M |
|
350
Crocs
CROX
$6.69B
| $53.3M | 0.07% |
2,700,960
+345,547
| +15% | +$8M |
|
Similar funds
D.E. Shaw & Co's Q2 2019 Portfolio in Review
As of Q2 2019, D.E. Shaw & Co held 4,048 positions worth $80.2B, up 3.6% from $77.4B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
D.E. Shaw & Co's Q2 2019 filing shows 499 new, 1,419 increased, 1,452 reduced and 416 closed positions. Its largest new stake was Zayo Group Holdings, Inc.: 5,926,898 shares worth $195M. The largest sale was Qualcomm, an estimated $836M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- D.E. Shaw & Co's largest Q2 2019 buy was Zayo Group Holdings, Inc.: 5,926,898 shares worth $195M.
- D.E. Shaw & Co added most to Alibaba in Q2 2019, an estimated $667M increase.
- D.E. Shaw & Co's biggest Q2 2019 reduction was Qualcomm, cutting an estimated $836M.
- D.E. Shaw & Co fully exited iShares Core S&P 500 ETF in Q2 2019, selling an estimated $42.7M.
- D.E. Shaw & Co's ten largest holdings make up 9.8% of its $80.2B portfolio in Q2 2019.
- D.E. Shaw & Co opened 499 new positions and closed 416 in Q2 2019.
- D.E. Shaw & Co's portfolio value rose 3.6% quarter-over-quarter to $80.2B.
Based on D.E. Shaw & Co's 13F filing for Q2 2019, filed 14 Aug 2019.